A controlled trial of photodynamic therapy of actinic keratosis comparing different red light sources

European journal of dermatology : EJD(2014)

引用 12|浏览9
暂无评分
摘要
Background Photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) with red light is well established for actinic keratosis (AK). Differences have been observed concerning pain and efficacy rates with different red light sources. Objectives: To compare pain scores, shortand long-term efficacy rates of PDT of multiple AKs when employing different red light sources. Material and methods In a controlled trial, 88 patients (310 AK lesions) received ALA-PDT in combination with either visible light (VIS) + water-filtered infrared A (wIRA) light (PhotoDyn ® 750 (PD750), 580–1400 nm) for 30 min or incoherent light (Waldmann ® 1200L (Wa1200L), 600–720 nm) for 10–11 min. Followup visits were performed after 1, 3, 6, and 12 months. If there was no complete cure after 1, 3 or 6 months, a second cycle of PDT was performed. Results Pain scores were significantly lower in patients illuminated with PD750 rather than Wa1200L. Patient complete clearance rates were 85% and 91% after 1 month, 79% and 92% after 3 months, 97% and 92% after 6 months, and 69% and 85% after 12 months in the PD750 and Wa1200L groups, respectively. Lesion complete clearance rates were 94% and 92% after 1 month, 88% and 97% after 3 months, 96% and 95% after 6 months, and 81% and 89% after 12 months in the PD750 and Wa1200L group, respectively. The efficacy rates were not significantly different. Conclusions AVIS + wIRA light source produced considerably less pain, while efficacy was not much affected in contrast to previously published studies, probably because the illumination time was longer in this study.
更多
查看译文
关键词
ala,actinic keratosis,broad-spectrum,controlled trial,photodynamic therapy,red light
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要